When fear takes over and everyone dumps everything, strong assets go on sale. Here's the deep breakdown — valuation, asymmetry, catalysts, and risk — for three ETFs ranked by conviction.
IGV YTD
−24%
MCHI YTD
−7.0%
VTV YTD
+3.7%
S&P 500 Fwd P/E
22x+
IGV
iShares Expanded Tech-Software Sector ETF · ~100–118 holdings · Pure software play
#1 Highest conviction
Price
~$80.30
YTD return
−24%
Fwd EPS growth
+15–20%
Dividend yield
~0%
The thesis
Software just posted its worst quarterly drawdown since Q4 2008 — down 24% — on a single fear: that AI will kill enterprise software budgets. That thesis is backwards. AI demands implementation layers, cloud orchestration, cybersecurity tooling, and integration middleware. These are IGV companies. Every dollar of AI capex flows through the software stack these firms own. The sell-off has fully priced in the worst case. The actual outcome — accelerating AI-driven demand — is not in the price at all. Forward earnings are still growing 15–20%. This is textbook asymmetry: the pessimism is baked in; the upside is free optionality.
Asymmetric setup
Upside
40–60%
Mean reversion in 12–18 months
Downside
10–15%
Support near 2025 lows
Risk/reward: 3-to-1 in your favour
↑ Upside 40–60%↓ Downside 10–15%
Top holdings
PLTR · Palantir
8.92%
MSFT · Microsoft
8.40%
ORCL · Oracle
8.18%
CRM · Salesforce
7.39%
PANW · Palo Alto
5.56%
INTU · Intuit
4.63%
APP · AppLovin
4.41%
CRWD · CrowdStrike
4.29%
NOW · ServiceNow
4.25%
ADBE · Adobe
4.25%
Key catalysts
AI implementation surge — every AI deployment needs the integration, security, and cloud tooling IGV companies own. Spending is accelerating.
Resilient enterprise budgets — CIOs are ring-fencing AI transformation spend. That's exactly where IGV revenue sits.
Historical mean reversion — every prior software correction of this magnitude (2022, 2018, 2008) saw 40–80% recoveries within 18 months.
Derating is complete — forward multiples near prior capitulation lows. Next move is re-rating on earnings delivery.
Risks to watch
Prolonged high rates delay enterprise capex and extend multiple compression further
AI genuinely cannibalises SaaS seats (Copilot replacing lower-tier subscriptions) — thesis breaks on sustained revenue misses
Broader tech regulation creating new compliance costs that compress operating margins
No dividend cushion — pure price return. If thesis takes 24+ months, opportunity cost is high
MCHI
iShares MSCI China ETF · ~579 constituents · Large/mid-cap A, H & Red Chip
#2 High conviction
Price
~$55.90
YTD return
−7.0%
Forward P/E
~11.0x
Dividend yield
~2.2%
The thesis
MCHI is trading at a forward P/E of 11x and a price-to-book of 1.51 — levels that historically only appear when the market has fully priced in catastrophe. The catastrophe (property drag, geopolitical tension, slow recovery) is already in the price. What is not in the price is any form of policy pivot, stimulus, or sentiment normalisation. The asymmetry is structural: the left tail is truncated because despair is already embedded in valuation. The right tail is fat because policy leverage in China is enormous — any incremental positive triggers rapid multiple expansion back toward long-term averages of 16–18x earnings.
Asymmetric setup
Upside
30–50%
Re-rate from 11x → 16–18x P/E
Downside
10–12%
Renewed risk-off / USD strength
Risk/reward: ~3.5-to-1 in your favour
↑ Upside 30–50%↓ Downside 10–12%
Top holdings
700 · Tencent
15.09%
9988 · Alibaba
9.83%
939 · China Construction
3.91%
PDD · PDD Holdings
2.71%
1810 · Xiaomi
2.56%
1398 · ICBC
2.18%
2318 · Ping An Insurance
1.95%
3690 · Meituan
1.92%
1211 · BYD
1.85%
3988 · Bank of China
1.73%
Tencent + Alibaba alone account for ~25% of the fund — heavily concentrated in China's two largest internet platforms
Valuation vs. history
Trailing P/E
13.9x
Forward P/E
11.0x
Price / book
1.51x
LT avg P/E
16–18x
Discount to avg
~35%
Dividend yield
2.16%
Key catalysts
Policy stimulus — Beijing has enormous fiscal and monetary levers untouched. Any deployment triggers rapid re-rating from a deeply depressed base.
China+1 re-shoring — global supply chain diversification is driving manufacturing investment into China by multinationals hedging other EM risks.
Institutional underweight unwinding — China is the largest single underweight in global EM portfolios. Any normalisation triggers massive inflows.
2.2% yield cushion — paid to wait while the thesis develops. Unlike zero-yield growth plays, you're compensated for patience.
Risks to watch
US-China geopolitical escalation (Taiwan, tariffs, sanctions) — the tail risk that invalidates the thesis rapidly
Property sector contagion spreading further into the banking system — watch Evergrande / Country Garden resolution
Renewed USD strength driving EM outflows and RMB currency pressure
Regulatory crackdowns on Alibaba and Tencent resuming — the two largest holdings in the fund
VTV
Vanguard Value ETF · CRSP US Large Cap Value Index · ~340 holdings · 0.04% ER
#3 Moderate conviction
Price
~$197
YTD return
+3.7%
Forward P/E
~16x
Dividend yield
~2.4%
The thesis
The value-growth valuation spread is near historic extremes — growth trades at 22x+ forward earnings while value sits in the mid-teens. Every prior time this spread reached these levels (2000, 2007, 2020), value outperformed growth by 20–35% over the following 12–24 months. VTV is not a catch-up trade. It is a regime shift: capital is structurally rotating away from overvalued growth into profitable, dividend-paying, balance-sheet-strong companies. The rotation has already begun — VTV is up 3.7% YTD while tech is down double digits. You're early, not late.
Asymmetric setup
Outperformance
20–35%
vs. growth over 12–24 months
Max drawdown
~5%
Dividends + defensives as floor
Short left tail. Long right tail.
↑ Outperformance 20–35%↓ Drawdown ~5%
Sector breakdown
BRK.B · Berkshire
3.08%
JPM · JPMorgan
3.00%
XOM · Exxon Mobil
2.51%
JNJ · Johnson & Johnson
2.34%
WMT · Walmart
2.19%
MU · Micron Technology
1.81%
ABBV · AbbVie
1.60%
PG · Procter & Gamble
1.53%
HD · Home Depot
1.48%
CVX · Chevron
1.40%
Valuation vs. S&P 500
VTV fwd P/E
~16x
S&P 500 fwd P/E
~22x
Discount to S&P
~27%
VTV dividend
~2.4%
S&P dividend
~1.3%
Expense ratio
0.04%
Key catalysts
Rotation already underway — multi-billion dollar inflows into value in Q1 2026. VTV is the primary institutional destination vehicle.
Higher-for-longer rates — financials (22% of VTV) benefit directly. Net interest margins expand. This actively hurts growth stocks.
Dividend compounding — 2.4% yield reinvested adds meaningful return on top of price appreciation. A floor IGV and MCHI don't offer.
Defensive moat — healthcare, staples, and utilities (~37% combined) provide recession-resistant revenue that holds in a macro downturn.
Risks to watch
A renewed AI-driven tech rally reverses the rotation — growth dominance resuming delays the value spread compression thesis by 12–24 months
Deep recession disproportionately hits financials and industrials (40%+ of VTV) — credit cycle turning is the key watch item
Faster-than-expected Fed rate cuts compress bank net interest margins — removes the key earnings tailwind for the largest sector weight
Not financial advice · All data as of early April 2026 · Do your own research · Past performance is not indicative of future results